1. Home
  2. KRYS vs PRI Comparison

KRYS vs PRI Comparison

Compare KRYS & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$327.51

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Logo Primerica Inc.

PRI

Primerica Inc.

N/A

Current Price

$273.75

Market Cap

8.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
KRYS
PRI
Founded
2015
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.9B
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
KRYS
PRI
Price
$327.51
$273.75
Analyst Decision
Strong Buy
Hold
Analyst Count
12
8
Target Price
★ $392.11
$324.50
AVG Volume (30 Days)
★ 204.3K
153.9K
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
★ 1.76%
EPS Growth
★ 128.00
67.10
EPS
3.62
★ 12.42
Revenue
$389,130,000.00
★ $3,291,713,000.00
Revenue This Year
$31.33
$5.39
Revenue Next Year
$27.55
$5.17
P/E Ratio
$93.08
★ $22.14
Revenue Growth
★ 33.94
6.56
52 Week Low
$179.16
$230.09
52 Week High
$382.54
$327.28

Technical Indicators

Market Signals
Indicator
KRYS
PRI
Relative Strength Index (RSI) 41.98 30.61
Support Level $331.79 $267.17
Resistance Level $371.16 $284.41
Average True Range (ATR) 9.85 5.16
MACD -1.37 -0.79
Stochastic Oscillator 17.44 11.33

Price Performance

Historical Comparison
KRYS
PRI

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

Share on Social Networks: